1. Home
  2. HXHX vs IMRN Comparison

HXHX vs IMRN Comparison

Compare HXHX & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HXHX
  • IMRN
  • Stock Information
  • Founded
  • HXHX 2003
  • IMRN 1994
  • Country
  • HXHX China
  • IMRN Australia
  • Employees
  • HXHX N/A
  • IMRN N/A
  • Industry
  • HXHX Trucking Freight/Courier Services
  • IMRN Biotechnology: Pharmaceutical Preparations
  • Sector
  • HXHX Industrials
  • IMRN Health Care
  • Exchange
  • HXHX Nasdaq
  • IMRN Nasdaq
  • Market Cap
  • HXHX 16.8M
  • IMRN 14.4M
  • IPO Year
  • HXHX 2025
  • IMRN N/A
  • Fundamental
  • Price
  • HXHX $0.75
  • IMRN $1.63
  • Analyst Decision
  • HXHX
  • IMRN
  • Analyst Count
  • HXHX 0
  • IMRN 0
  • Target Price
  • HXHX N/A
  • IMRN N/A
  • AVG Volume (30 Days)
  • HXHX 256.3K
  • IMRN 392.3K
  • Earning Date
  • HXHX 04-30-2026
  • IMRN 08-29-2025
  • Dividend Yield
  • HXHX N/A
  • IMRN N/A
  • EPS Growth
  • HXHX N/A
  • IMRN N/A
  • EPS
  • HXHX 0.26
  • IMRN N/A
  • Revenue
  • HXHX $25,571,810.00
  • IMRN $4,777,422.00
  • Revenue This Year
  • HXHX N/A
  • IMRN N/A
  • Revenue Next Year
  • HXHX N/A
  • IMRN N/A
  • P/E Ratio
  • HXHX $2.82
  • IMRN N/A
  • Revenue Growth
  • HXHX N/A
  • IMRN 48.63
  • 52 Week Low
  • HXHX $0.56
  • IMRN $1.42
  • 52 Week High
  • HXHX $6.29
  • IMRN $2.48
  • Technical
  • Relative Strength Index (RSI)
  • HXHX N/A
  • IMRN 34.13
  • Support Level
  • HXHX N/A
  • IMRN $1.42
  • Resistance Level
  • HXHX N/A
  • IMRN $1.67
  • Average True Range (ATR)
  • HXHX 0.00
  • IMRN 0.14
  • MACD
  • HXHX 0.00
  • IMRN -0.06
  • Stochastic Oscillator
  • HXHX 0.00
  • IMRN 24.10

About HXHX Haoxin Holdings Limited Class A Ordinary Shares

Haoxin Holdings Ltd is engaged in the logistics industry, including container provider of temperature-controlled truckload service and urban delivery services in China, freight forwarding, cold chain transportation and other businesses. The types of goods involved are all kinds of new energy materials that require low temperature, heat preservation, and constant temperature, electronic products, medicines, meat, fruits, vegetables and others.

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.

Share on Social Networks: